Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York

Kathy Kamath, Elisabeth Baum-Jones, Gregory Jordan, Winston Haynes, Rebecca Waitz, John Shon, Steve Kujawa, Lyn Fitzgibbons, Debra Kessler, Larry Luchsinger, Yale IMPACT Team, Patrick Daugherty
doi: https://doi.org/10.1101/2020.10.19.20215368

Article usage

Article usage: October 2020 to December 2024

AbstractFullPdf
Oct 2020134016211
Nov 2020392583
Dec 2020241340
Jan 2021175121
Feb 20211301425
Mar 20211091117
Apr 202185512
May 202194312
Jun 202174218
Jul 202148211
Aug 202148720
Sep 202142314
Oct 202154226
Nov 202141326
Dec 202142111
Jan 20223289
Feb 20223806
Mar 20222208
Apr 20222805
May 202231215
Jun 20223216
Jul 20222612
Aug 20222616
Sep 202240010
Oct 20223005
Nov 20221303
Dec 20222718
Jan 20232104
Feb 20233437
Mar 20232305
Apr 20234914
May 202316111
Jun 20231157
Jul 20231403
Aug 202323108
Sep 20232746
Oct 20231722
Nov 20232331
Dec 20232827
Jan 20241221
Feb 20241716
Mar 202413410
Apr 2024874
May 20241417
Jun 20241135
Jul 202417310
Aug 20241225
Sep 202424210
Oct 20243198
Nov 20241529
Dec 2024913
Back to top
Posted October 21, 2020.
Download PDF
Data/Code
Email
Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York
Kathy Kamath, Elisabeth Baum-Jones, Gregory Jordan, Winston Haynes, Rebecca Waitz, John Shon, Steve Kujawa, Lyn Fitzgibbons, Debra Kessler, Larry Luchsinger, Yale IMPACT Team, Patrick Daugherty
medRxiv 2020.10.19.20215368; doi: https://doi.org/10.1101/2020.10.19.20215368
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area